$HUN
Huntsman CORP

2022 Q1 Form 10-Q Financial Statement

#000143774922010014 Filed on April 28, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $2.389B $1.837B
YoY Change 30.05% 15.32%
Cost Of Revenue $1.824B $1.445B
YoY Change 26.23% 11.5%
Gross Profit $565.0M $392.0M
YoY Change 44.13% 31.99%
Gross Profit Margin 23.65% 21.34%
Selling, General & Admin $216.0M $207.0M
YoY Change 4.35% 4.02%
% of Gross Profit 38.23% 52.81%
Research & Development $38.00M $38.00M
YoY Change 0.0% 5.56%
% of Gross Profit 6.73% 9.69%
Depreciation & Amortization $71.00M $74.00M
YoY Change -4.05% 10.45%
% of Gross Profit 12.57% 18.88%
Operating Expenses $261.0M $266.0M
YoY Change -1.88% 9.47%
Operating Profit $304.0M $126.0M
YoY Change 141.27% 133.33%
Interest Expense -$14.00M -$19.00M
YoY Change -26.32% 5.56%
% of Operating Profit -4.61% -15.08%
Other Income/Expense, Net $1.000M $7.000M
YoY Change -85.71% -30.0%
Pretax Income $304.0M $133.0M
YoY Change 128.57% -314.52%
Income Tax $65.00M $34.00M
% Of Pretax Income 21.38% 25.56%
Net Earnings $223.0M $83.00M
YoY Change 168.67% -88.23%
Net Earnings / Revenue 9.33% 4.52%
Basic Earnings Per Share $1.05 $0.38
Diluted Earnings Per Share $1.04 $0.37
COMMON SHARES
Basic Shares Outstanding 212.7M 220.4M
Diluted Shares Outstanding 215.4M 222.6M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $807.0M $673.0M
YoY Change 19.91% -57.78%
Cash & Equivalents $807.0M $673.0M
Short-Term Investments
Other Short-Term Assets $156.0M $228.0M
YoY Change -31.58% 57.24%
Inventory $1.382B $1.006B
Prepaid Expenses
Receivables $1.285B $1.010B
Other Receivables $358.0M $12.00M
Total Short-Term Assets $3.988B $2.929B
YoY Change 36.16% -22.39%
LONG-TERM ASSETS
Property, Plant & Equipment $2.551B $2.514B
YoY Change 1.47% 6.66%
Goodwill $650.0M $739.0M
YoY Change -12.04% 86.62%
Intangibles $461.0M $422.0M
YoY Change 9.24% 20.23%
Long-Term Investments $485.0M $411.0M
YoY Change 18.0% -3.52%
Other Assets $673.0M $571.0M
YoY Change 17.86% 26.05%
Total Long-Term Assets $5.414B $5.371B
YoY Change 0.8% 14.67%
TOTAL ASSETS
Total Short-Term Assets $3.988B $2.929B
Total Long-Term Assets $5.414B $5.371B
Total Assets $9.402B $8.300B
YoY Change 13.28% -1.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.252B $909.0M
YoY Change 37.73% 10.18%
Accrued Expenses $732.0M $505.0M
YoY Change 44.95% -31.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $21.00M $57.00M
YoY Change -63.16% -57.46%
Total Short-Term Liabilities $2.118B $1.564B
YoY Change 35.42% -11.84%
LONG-TERM LIABILITIES
Long-Term Debt $1.529B $1.510B
YoY Change 1.26% -26.31%
Other Long-Term Liabilities $679.0M $875.0M
YoY Change -22.4% 5.04%
Total Long-Term Liabilities $2.208B $2.385B
YoY Change -7.42% -17.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.118B $1.564B
Total Long-Term Liabilities $2.208B $2.385B
Total Liabilities $4.862B $4.566B
YoY Change 6.48% -10.03%
SHAREHOLDERS EQUITY
Retained Earnings $2.595B $1.603B
YoY Change 61.88% 18.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.343B $3.563B
YoY Change
Total Liabilities & Shareholders Equity $9.402B $8.300B
YoY Change 13.28% -1.87%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $223.0M $83.00M
YoY Change 168.67% -88.23%
Depreciation, Depletion And Amortization $71.00M $74.00M
YoY Change -4.05% 10.45%
Cash From Operating Activities $85.00M -$17.00M
YoY Change -600.0% -77.33%
INVESTING ACTIVITIES
Capital Expenditures $69.00M $98.00M
YoY Change -29.59% 60.66%
Acquisitions $0.00 $240.0M
YoY Change -100.0% -30.64%
Other Investing Activities -$4.000M $0.00
YoY Change -100.0%
Cash From Investing Activities -$65.00M -$323.0M
YoY Change -79.88% -121.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $198.0M -$3.000M
YoY Change -6700.0% -103.13%
Debt Paid & Issued, Net $3.000M $548.0M
YoY Change -99.45%
Cash From Financing Activities -$252.0M -$579.0M
YoY Change -56.48% 63.56%
NET CHANGE
Cash From Operating Activities $85.00M -$17.00M
Cash From Investing Activities -$65.00M -$323.0M
Cash From Financing Activities -$252.0M -$579.0M
Net Change In Cash -$234.0M -$920.0M
YoY Change -74.57% -186.06%
FREE CASH FLOW
Cash From Operating Activities $85.00M -$17.00M
Capital Expenditures $69.00M $98.00M
Free Cash Flow $16.00M -$115.0M
YoY Change -113.91% -15.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
209975156
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
261055993
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
259701770
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
209798078
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23000000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
214170287
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
51080837
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
45531489
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2125
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.07 pure
CY2021Q1 us-gaap Environmental Costs Recognized Capitalized In Period
EnvironmentalCostsRecognizedCapitalizedInPeriod
7000000 USD
CY2022Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
5000000 USD
CY2022Q1 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
1000000 USD
CY2022Q1 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
4000000 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
44000000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
54000000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
807000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1041000000 USD
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1285000000 USD
CY2021Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
1159000000 USD
CY2022Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
25000000 USD
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
27000000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1382000000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3928000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1201000000 USD
CY2022Q1 hun Receivables Associated With Legal Settlement Current
ReceivablesAssociatedWithLegalSettlementCurrent
333000000 USD
CY2021Q4 hun Receivables Associated With Legal Settlement Current
ReceivablesAssociatedWithLegalSettlementCurrent
333000000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
156000000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
167000000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
3988000000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2551000000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2576000000 USD
CY2022Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
485000000 USD
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
470000000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
461000000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
469000000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
650000000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
650000000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
204000000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
206000000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
390000000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
403000000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
673000000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
690000000 USD
CY2022Q1 us-gaap Assets
Assets
9402000000 USD
CY2021Q4 us-gaap Assets
Assets
9392000000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1252000000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1148000000 USD
CY2022Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
63000000 USD
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
60000000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
732000000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
780000000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
21000000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12000000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
50000000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
51000000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2118000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2051000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1529000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1538000000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
178000000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
161000000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
358000000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
370000000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
679000000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
713000000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
4862000000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
4833000000 USD
CY2022Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3000000 USD
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
3000000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4152000000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4102000000 USD
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1144000000 USD
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
934000000 USD
CY2022Q1 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
49000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
83000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.04
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.38
CY2021Q4 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
25000000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2595000000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2435000000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1214000000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1203000000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
4343000000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
4378000000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
197000000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
181000000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4540000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4559000000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9402000000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9392000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2389000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1837000000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1824000000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
1445000000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
565000000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
392000000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
216000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
207000000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38000000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38000000 USD
CY2022Q1 hun Restructuring Settlement And Impairment Provisions Credits
RestructuringSettlementAndImpairmentProvisionsCredits
0 USD
CY2021Q1 hun Restructuring Settlement And Impairment Provisions Credits
RestructuringSettlementAndImpairmentProvisionsCredits
24000000 USD
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-7000000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3000000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
261000000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
266000000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
304000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
126000000 USD
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14000000 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-19000000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15000000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
38000000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2000000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-19000000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
304000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
133000000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
239000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
99000000 USD
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 USD
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
240000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
100000000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
223000000 USD
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212700000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220400000
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.03
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.37
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215400000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222600000
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
222000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
82000000 USD
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1000000 USD
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
223000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
83000000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
240000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
100000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-9000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-19000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-1000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
0 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
228000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
87000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
16000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
17000000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
212000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
70000000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4559000000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
240000000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000000 USD
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
0 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000 USD
CY2022Q1 hun Equity Impact Of Recognition Of Stockbased Compensation Including Unearned Stockbased Compensation
EquityImpactOfRecognitionOfStockbasedCompensationIncludingUnearnedStockbasedCompensation
9000000 USD
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
13000000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
210000000 USD
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
45000000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4540000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3673000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
100000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000000 USD
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5000000 USD
CY2021Q1 hun Equity Impact Of Recognition Of Stockbased Compensation Including Unearned Stockbased Compensation
EquityImpactOfRecognitionOfStockbasedCompensationIncludingUnearnedStockbasedCompensation
8000000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65000000 USD
CY2021Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
6000000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
36000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3734000000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
240000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
100000000 USD
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 USD
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
239000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
99000000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15000000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
38000000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-2000000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-19000000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
71000000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
74000000 USD
CY2022Q1 hun Noncash Lease Expense
NoncashLeaseExpense
16000000 USD
CY2021Q1 hun Noncash Lease Expense
NoncashLeaseExpense
17000000 USD
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 USD
CY2021Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
8000000 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13000000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
9000000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
134000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
117000000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
187000000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
156000000 USD
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-16000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
10000000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
30000000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
120000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
94000000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-41000000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
20000000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-26000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-7000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
85000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16000000 USD
CY2022Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
CY2021Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
85000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17000000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
69000000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
98000000 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
240000000 USD
CY2022Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
CY2021Q1 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
15000000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-252000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-323000000 USD
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
8000000 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
9000000 USD
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3000000 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
548000000 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
46000000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
37000000 USD
CY2022Q1 hun Payments For Repurchase And Cancellation Of Stock Awards
PaymentsForRepurchaseAndCancellationOfStockAwards
13000000 USD
CY2021Q1 hun Payments For Repurchase And Cancellation Of Stock Awards
PaymentsForRepurchaseAndCancellationOfStockAwards
6000000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
203000000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-579000000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-1000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-234000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-920000000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1041000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1593000000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
807000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
673000000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
9000000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
16000000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
32000000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8000000 USD
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b><em style="font: inherit;">1.</em> GENERAL</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><span style="text-transform:uppercase;"><b>C<span style="font-family:Times New Roman;font-size:7pt;">ertain</span> D<span style="font-family:Times New Roman;font-size:7pt;">efinitions</span></b></span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">For convenience in this report, the terms “Company,” “Huntsman,” “our,” “us” or “we” <em style="font: inherit;"> may </em>be used to refer to Huntsman Corporation and, unless the context otherwise requires, its subsidiaries and predecessors. In this report, “Huntsman International” refers to Huntsman International LLC (our wholly-owned subsidiary).</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;text-indent:36pt;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">In this report, we <em style="font: inherit;"> may </em>use, without definition, the common names of competitors or other industry participants. We <em style="font: inherit;"> may </em>also use the common names or abbreviations for certain chemicals or products.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;text-indent:36pt;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><span style="text-transform:uppercase;"><b>I<span style="font-family:Times New Roman;font-size:7pt;">nterim</span> F<span style="font-family:Times New Roman;font-size:7pt;">inancial</span> S<span style="font-family:Times New Roman;font-size:7pt;">tatements</span></b></span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our unaudited interim condensed consolidated financial statements and Huntsman International’s unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP” or “U.S. GAAP”) and in management’s opinion reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results of operations, comprehensive income (loss), financial position and cash flows for the periods presented. Results for interim periods are <em style="font: inherit;">not</em> necessarily indicative of those to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to consolidated financial statements included in the Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2021</em> for our Company and Huntsman International.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">​</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><span style="text-transform:uppercase;"><b>D<span style="font-family:Times New Roman;font-size:7pt;">escription</span> <span style="font-family:Times New Roman;font-size:7pt;">of</span> B<span style="font-family:Times New Roman;font-size:7pt;">usinesses</span></b></span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We are a global manufacturer of differentiated organic chemical products. We operate in four segments: Polyurethanes, Performance Products, Advanced Materials and Textile Effects. Our products comprise a broad range of chemicals and formulations, which we market globally to a diversified group of consumer and industrial customers. Our products are used in a wide range of applications, including those in the adhesives, aerospace, automotive, construction products, durable and non-durable consumer products, electronics, insulation, medical, packaging, coatings and construction, power generation, refining, synthetic fiber, textile chemicals and dyes industries. We are a leading global producer in many of our key product lines, including MDI, amines, maleic anhydride, epoxy-based polymer formulations, textile chemicals and dyes.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">​</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We operate our businesses through Huntsman International, our wholly-owned subsidiary. Huntsman International is a Delaware limited liability company and was formed in <em style="font: inherit;">1999.</em></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;/*! font-variant:small-caps; */margin:0pt;text-align:left;"><span style="text-transform:uppercase;"><b>H<span style="font-family:Times New Roman;font-size:7pt;">untsman</span> C<span style="font-family:Times New Roman;font-size:7pt;">orporation and </span>H<span style="font-family:Times New Roman;font-size:7pt;">untsman</span> I<span style="font-family:Times New Roman;font-size:7pt;">nternational</span> F<span style="font-family:Times New Roman;font-size:7pt;">inancial</span> S<span style="font-family:Times New Roman;font-size:7pt;">tatements</span></b></span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Except where otherwise indicated, these notes relate to the condensed consolidated financial statements for both our Company and Huntsman International. The differences between our financial statements and Huntsman International’s financial statements relate primarily to the following:</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">​</p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">●</p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">purchase accounting recorded at our Company for the <em style="font: inherit;">2003</em> step-acquisition of Huntsman International Holdings LLC, the former parent company of Huntsman International that was merged into Huntsman International in <em style="font: inherit;">2005;</em> and</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">​</p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">●</p> </td><td> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">the different capital structures.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">​</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">​<span style="text-transform:uppercase;"><b>P<span style="font-family:Times New Roman;font-size:7pt;">rinciples of</span> C<span style="font-family:Times New Roman;font-size:7pt;">onsolidation</span></b></span></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><b>​</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 45pt;">Our condensed consolidated financial statements include the accounts of our wholly-owned and majority-owned subsidiaries and any variable interest entities for which we are the primary beneficiary. Intercompany accounts and transactions have been eliminated.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">​</p> <p style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b style="text-transform:uppercase; font-size:10pt; font-variant-caps:small-caps">R<span style="font-family:Times New Roman; font-size:7pt">ecent </span>D<span style="font-family:Times New Roman; font-size:7pt">evelopments</span></b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b>Share Repurchase Program</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: left;">On <em style="font: inherit;"> March 25, 2022, </em>our Board of Directors increased the authorization of our existing share repurchase program from $1 billion to $2 billion. Repurchases <em style="font: inherit;"> may </em>be made through the open market or in privately negotiated transactions, and repurchases <em style="font: inherit;"> may </em>be commenced or suspended from time to time without prior notice. Shares of common stock acquired through the repurchase program are held in treasury at cost.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt; text-indent: -9pt;"><b>Dividend Increase</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: left;">On <em style="font: inherit;"> February 14, 2022, </em>our Board of Directors declared a $0.2125 per share cash dividend on our common stock. This represents a 13% increase from the previous dividend.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><b style="text-transform: uppercase; font-size: 10pt; font-variant-caps: small-caps;">U<span style="font-family:Times New Roman;font-size:7pt;">se of</span> </b><b style="text-transform: uppercase; font-size: 10pt; font-variant-caps: small-caps;">E<span style="font-family:Times New Roman;font-size:7pt;">stimates</span></b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;font-variant:small-caps;margin:0pt;text-align:left;"><b>​</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p>
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2125
CY2022Q1 hun Common Stock Dividends Increase Percent
CommonStockDividendsIncreasePercent
0.13 pure
CY2021Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1841000000 USD
CY2021Q1 hun Business Acquisition Pro Forma Net Income Loss Including Noncontrolling Interests
BusinessAcquisitionProFormaNetIncomeLossIncludingNoncontrollingInterests
88000000 USD
CY2021Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
71000000 USD
CY2022Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
332000000 USD
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
282000000 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
66000000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
52000000 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1029000000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
909000000 USD
CY2022Q1 us-gaap Inventory Gross
InventoryGross
1427000000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
1243000000 USD
CY2022Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
45000000 USD
CY2021Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
42000000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
1382000000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
1201000000 USD
CY2022Q1 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.07 pure
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
31000000 USD
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
24000000 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
31000000 USD
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
24000000 USD
CY2022Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
12000000 USD
CY2022Q1 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
12000000 USD
CY2022Q1 hun Restructuring Reserve Other Non Cash Charges
RestructuringReserveOtherNonCashCharges
0 USD
CY2021Q1 hun Restructuring Reserve Other Non Cash Charges
RestructuringReserveOtherNonCashCharges
8000000 USD
CY2022Q1 hun Restructuring Impairment And Plant Closing Costs
RestructuringImpairmentAndPlantClosingCosts
0 USD
CY2021Q1 hun Restructuring Impairment And Plant Closing Costs
RestructuringImpairmentAndPlantClosingCosts
24000000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
21000000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12000000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1529000000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1550000000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1550000000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1538000000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
1550000000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1550000000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9000000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
10000000 USD
CY2022Q1 hun Number Of Instruments Categorized As Level Three
NumberOfInstrumentsCategorizedAsLevelThree
0 pure
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
0 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2389000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2389000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1837000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1837000000 USD
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
13000000 USD
CY2021Q1 us-gaap Pension And Other Postretirement Benefit Contributions
PensionAndOtherPostretirementBenefitContributions
14000000 USD
CY2022Q1 us-gaap Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
36000000 USD
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5549348
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
210000000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2125
CY2022Q1 hun Common Stock Dividend Increase Percent
CommonStockDividendIncreasePercent
0.13 pure
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
45000000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
36000000 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.2125
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1625
CY2022Q1 us-gaap Environmental Costs Recognized Capitalized In Period
EnvironmentalCostsRecognizedCapitalizedInPeriod
7000000 USD
CY2021Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
5000000 USD
CY2021Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
1000000 USD
CY2021Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
4000000 USD
CY2022Q1 hun Maximum Period For Payment Of Remediation Liabilities
MaximumPeriodForPaymentOfRemediationLiabilities
P30Y
CY2022Q1 hun Site Contingency Number Of Former Facility Or Third Party Sites With Claims Against Entity For Cleanup Liabilities
SiteContingencyNumberOfFormerFacilityOrThirdPartySitesWithClaimsAgainstEntityForCleanupLiabilities
9 pure
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11000000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9000000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4000000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1000000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4054000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.62
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
515000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
19.46
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
19000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
26.68
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3520000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.91
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
55000000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3092000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.56
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M24D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49000000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11000000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
2000000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
1000000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
222000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
82000000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
223000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
83000000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212700000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
220400000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2700000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2200000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215400000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222600000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 pure
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2389000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1837000000 USD
CY2022Q1 hun Income Loss From Operations Before Interest Tax Depreciation And Amortization Net
IncomeLossFromOperationsBeforeInterestTaxDepreciationAndAmortizationNet
465000000 USD
CY2021Q1 hun Income Loss From Operations Before Interest Tax Depreciation And Amortization Net
IncomeLossFromOperationsBeforeInterestTaxDepreciationAndAmortizationNet
339000000 USD
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-14000000 USD
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-19000000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
71000000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
74000000 USD
CY2022Q1 hun Corporate And Other Costs Net
CorporateAndOtherCostsNet
50000000 USD
CY2021Q1 hun Corporate And Other Costs Net
CorporateAndOtherCostsNet
50000000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000000 USD
CY2022Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
6000000 USD
CY2021Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
9000000 USD
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-2000000 USD
CY2021Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-19000000 USD
CY2022Q1 hun Litigation Settlements And Related Income
LitigationSettlementsAndRelatedIncome
12000000 USD
CY2021Q1 hun Litigation Settlements And Related Income
LitigationSettlementsAndRelatedIncome
2000000 USD
CY2022Q1 hun Income Associated With Legal Settlement Net
IncomeAssociatedWithLegalSettlementNet
-1000000 USD
CY2021Q1 hun Income Associated With Legal Settlement Net
IncomeAssociatedWithLegalSettlementNet
0 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-4000000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2022Q1 hun Gain Loss Transition Services Arrangements
GainLossTransitionServicesArrangements
1000000 USD
CY2021Q1 hun Gain Loss Transition Services Arrangements
GainLossTransitionServicesArrangements
1000000 USD
CY2022Q1 hun Information Technology Project Implementation Costs
InformationTechnologyProjectImplementationCosts
2000000 USD
CY2021Q1 hun Information Technology Project Implementation Costs
InformationTechnologyProjectImplementationCosts
1000000 USD
CY2022Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-14000000 USD
CY2021Q1 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-22000000 USD
CY2022Q1 hun Incident Remediation Costs Credits
IncidentRemediationCostsCredits
-0 USD
CY2021Q1 hun Incident Remediation Costs Credits
IncidentRemediationCostsCredits
4000000 USD
CY2022Q1 hun Restructuring Settlement Impairment And Transition Costs Credits
RestructuringSettlementImpairmentAndTransitionCostsCredits
3000000 USD
CY2021Q1 hun Restructuring Settlement Impairment And Transition Costs Credits
RestructuringSettlementImpairmentAndTransitionCostsCredits
24000000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
304000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
133000000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
65000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000000 USD
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 USD
CY2021Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1000000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
240000000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
100000000 USD

Files In Submission

Name View Source Status
0001437749-22-010014-index-headers.html Edgar Link pending
0001437749-22-010014-index.html Edgar Link pending
0001437749-22-010014.txt Edgar Link pending
0001437749-22-010014-xbrl.zip Edgar Link pending
ex_342616.htm Edgar Link pending
ex_342617.htm Edgar Link pending
ex_342618.htm Edgar Link pending
ex_342619.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hun-20220331.xsd Edgar Link pending
hun-20220331_cal.xml Edgar Link unprocessable
hun-20220331_def.xml Edgar Link unprocessable
hun-20220331_lab.xml Edgar Link unprocessable
hun-20220331_pre.xml Edgar Link unprocessable
hun20220302_10q.htm Edgar Link pending
hun20220302_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending